About The Cooper Companies, Inc
Ticker
info
COO
Trading on
info
NASDAQ
ISIN
info
US2166485019
Industry
info
Medical Instruments & Supplies
Sector
info
Healthcare
CEO
info
Albert G. White III
Headquarters
info
6101 Bollinger Canyon Road, San Ramon, CA, United States, 94583
Employees
info
16,000
Website
info
coopercos.com
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including paragard contraceptive intrauterine devices; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Metrics
BasicAdvanced
Market cap
info
$14.1B
P/E ratio
info
34.67
EPS
info
$2.04
Dividend Yield
info
0.00%
Beta
info
1.06
Forward P/E ratio
info
16.34
EBIDTA
info
$1.11B
Ex dividend date
info
2023-07-26
Price & volume
Market cap
info
$14.1B
Average daily volume
info
2.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
34.67
Forward P/E
info
16.34
PEG ratio
info
0.89
Trailing P/E
info
34.67
Price to sales
info
3.48
Price to book
info
1.68
Earnings
EPS
info
$2.04
EPS estimate (current quarter)
info
$1.07
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$1.11B
Revenues (TTM)
info
$4.05B
Revenues per share (TTM)
info
$20.28
Technicals
Beta
info
1.06
52-week High
info
$106.63
52-week Low
info
$61.78
50-day moving average
info
$69.31
200-day moving average
info
$76.59
Short ratio
info
2.93
Short %
info
4.21%
Management effectiveness
ROE (TTM)
info
5.01%
ROA (TTM)
info
3.79%
Profit margin
info
10.08%
Gross profit margin
info
$2.71B
Operating margin
info
16.57%
Growth
Quarterly earnings growth (YoY)
info
-5.80%
Quarterly revenue growth (YoY)
info
5.70%
Share stats
Outstanding Shares
info
199M
Float
info
198M
Insiders %
info
0.61%
Institutions %
info
103.31%
Analyst Insights & forecasts
info

58% Buy

42% Hold

0% Sell

Based on information from 19 analysts.

Average price target

info
$83.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$1.04
$1.00
4.00%
Q4 • 24Beat
$0.92
$0.91
1.10%
Q1 • 25Beat
$0.96
$0.93
3.23%
Q2 • 25Beat
$1.10
$1.07
2.80%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$1B
$87.7M
8.75%
Q2 • 25
$1.06B
$98.3M
9.27%
Q3 • 25
5.79%
12.09%
5.96%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$12.4B
$4.13B
33.23%
Q2 • 25
$12.4B
$4.02B
32.51%
Q3 • 25
-0.30%
-2.47%
-2.18%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$96.2M
$-79.2M
$-8.6M
$18.1M
Q2 • 25
$261M
$-98.1M
$-156M
$165M
Q3 • 25
171.73%
23.86%
1,717.44%
808.84%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a The Cooper Companies, Inc share?
Collapse

The Cooper Companies, Inc shares are currently traded for undefined per share.

How many shares does The Cooper Companies, Inc have?
Collapse

The Cooper Companies, Inc currently has 199M shares.

Does The Cooper Companies, Inc pay dividends?
Collapse

No, The Cooper Companies, Inc doesn't pay dividends.

What is The Cooper Companies, Inc 52 week high?
Collapse

The Cooper Companies, Inc 52 week high is $106.63.

What is The Cooper Companies, Inc 52 week low?
Collapse

The Cooper Companies, Inc 52 week low is $61.78.

What is the 200-day moving average of The Cooper Companies, Inc?
Collapse

The Cooper Companies, Inc 200-day moving average is $76.59.

Who is The Cooper Companies, Inc CEO?
Collapse

The CEO of The Cooper Companies, Inc is Albert G. White III.

How many employees The Cooper Companies, Inc has?
Collapse

The Cooper Companies, Inc has 16,000 employees.

What is the market cap of The Cooper Companies, Inc?
Collapse

The market cap of The Cooper Companies, Inc is $14.1B.

What is the P/E of The Cooper Companies, Inc?
Collapse

The current P/E of The Cooper Companies, Inc is 34.67.

What is the EPS of The Cooper Companies, Inc?
Collapse

The EPS of The Cooper Companies, Inc is $2.04.

What is the PEG Ratio of The Cooper Companies, Inc?
Collapse

The PEG Ratio of The Cooper Companies, Inc is 0.89.

What do analysts say about The Cooper Companies, Inc?
Collapse

According to the analysts The Cooper Companies, Inc is considered a buy.